US 7037912
Protein kinase inhibitors
expired A61PA61P17/06A61P19/02
Quick answer
US patent 7037912 (Protein kinase inhibitors) held by Theravance, Inc. expires Mon Apr 27 2026 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.
Key facts
- Applicant
- Theravance, Inc.
- Grant date
- Tue May 02 2006 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Apr 27 2026 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 17
- CPC classes
- A61P, A61P17/06, A61P19/02, A61P3/10